COPD Exacerbation Follow Up (NCT07118306)
A Multicenter Study of the Impact of a COPD Identification and Referral System on Patient Follow Up and Outcomes After an Acute COPD Exacerbation Resulting in an Emergency Department Visit or Hospitalization
🩺 Plain-English Summary (8th-Grade Level)
The goal of this study is to evaluate the impact of implementing an AI-enabled clinical workflow tool (Viz COPD) on respiratory specialist follow up and clinical outcomes after an acute exacerbation.
Who can join: Review the eligibility criteria below.
Location: Advocate Lutheran General Hospital — Park Ridge, Illinois
Age range: 40 Years
📋 "Do I Qualify?" — 1-Minute Self Screener
Instant ChecklistFull eligibility criteria are available on the official NIH protocol. View the criteria ↗
📍 All Participating Trial Locations (4 Sites)
- Advocate Lutheran General Hospital — Park Ridge, Illinois
- Cooper University Health Care — Cherry Hill, New Jersey
- Thomas Jefferson University — Philadelphia, Pennsylvania
- Aurora St. Luke's Medical Center — Milwaukee, Wisconsin
📞 Contact the Study Coordinator
Phone: (920) 360-9415
Email: alexander.albers@aah.org
Coordinator details come directly from the registered NIH protocol. Confirm the study is still recruiting before traveling.
💰 Cost, Insurance & Patient Rights
- 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
- Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
- Voluntary Participation: You may withdraw at any time without affecting your standard medical care.
More studies in COPD (Chronic Obstructive Pulmonary Disease)
- Inhaled Treprostinil for Dyspnea and Exercise Intolerance in Mild COPD — Edmonton, Alberta
- Modulating Locomotor-Respiratory Coupling Through Adaptive Exoskeleton Assistance in Patients With COPD — Omaha, Nebraska
- Development And Evaluation of An Adaptive Web-Based Intervention for COPD — Aurora, Colorado
- Inhaled Treprostinil (Tyvaso Nebulizer) For COPD Patients With Hypoxemia — Durham, North Carolina
- Rehabilitation in Safety-net Environments (RISE) to Improve Outcomes in Vulnerable Patients With COPD — San Francisco, California
Explore by condition: All COPD (Chronic Obstructive Pulmonary Disease) clinical trials
💡 How to Participate
- Check the checklist above to see if you may qualify.
- Contact the study coordinator using the phone/email above.
- Ask about the visit schedule, what is covered at no cost, and any travel support.
- Confirm with your own doctor before making a decision.